Home › Funds › ADAGE CAPITAL PARTNERS GP, L.L.C. › ABBV

ADAGE CAPITAL PARTNERS GP, L.L.C. position in ABBV

ABBVIE INC · Health Care

ADAGE CAPITAL PARTNERS GP, L.L.C. reported holding 1,598,568 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$402.3M, representing 0.56% of its reported portfolio and ranking #24 among its reported holdings. ADAGE CAPITAL PARTNERS GP, L.L.C. has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.60M sh
Reported value held$402.26M
Portfolio Weight0.56%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAGE CAPITAL PARTNERS GP, L.L.C.'s ABBV position evolved

ADAGE CAPITAL PARTNERS GP, L.L.C. first disclosed a stake in ABBV in Q3 2023 at 2,014,817 shares (US$300.3M). The position peaked in Q1 2024 at 2,407,145 shares, worth US$438.3M. Across 12 filings, ADAGE CAPITAL PARTNERS GP, L.L.C. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,598,568 shares valued at US$402.3M — an increase of 128,297 shares quarter over quarter.. Notable position changes include a 41% trim in Q2 2024 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.01M $300.33M New
Q4 2023 2.38M $368.71M Add
Q1 2024 2.41M $438.34M Add
Q2 2024 1.42M $243.61M Reduce
Q3 2024 1.66M $327.38M Add
Q4 2024 1.73M $307.31M Add
Q1 2025 1.80M $376.87M Add
Q2 2025 1.62M $300.49M Reduce
Q3 2025 1.84M $427.14M Add
Q4 2025 1.51M $344.73M Reduce
Q1 2026 1.47M $319.77M Reduce
Q2 2026 1.60M $402.26M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has ADAGE CAPITAL PARTNERS GP, L.L.C. held ABBV?

ADAGE CAPITAL PARTNERS GP, L.L.C. has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ADAGE CAPITAL PARTNERS GP, L.L.C.'s current position in ABBV?

As of Q2 2026, ADAGE CAPITAL PARTNERS GP, L.L.C. holds 1.60M shares of ABBV (ABBVIE INC), valued at $402.26M, representing 0.56% of its reported portfolio and ranking #24.

Has ADAGE CAPITAL PARTNERS GP, L.L.C. been buying or selling ABBV?

In the latest 13F filing (Q2 2026), ADAGE CAPITAL PARTNERS GP, L.L.C. increased its position in ABBV. The position peaked in Q1 2024 at 2.41M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.